Aim In addition to respiratory symptoms, COVID‐19 can present with gastrointestinal
complaints suggesting possible faeco‐oral transmission. The primary aim of this review was …

Serrated polyps have been recognised in the last decade as important premalignant lesions
accounting for between 15% and 30% of colorectal cancers. There is therefore a clinical …

Background Low-dose aspirin has been shown to reduce the incidence of cancer, but its
role in the treatment of cancer is uncertain. Objectives We conducted a systematic search of …

Objectives To determine the differences between in-situ, prefixation and postfixation
colorectal polyp measurements, their clinical impact upon determining adenoma …

Familial adenomatous polyposis (FAP) and attenuated FAP are autosomal dominant
disorders characterised by multiple colorectal adenomas and cancers. Both are caused by …

The biochemical response to ursodeoxycholic acid (UDCA)—so‐called “treatment
response”—strongly predicts long‐term outcome in primary biliary cholangitis (PBC) …

Heritable factors account for approximately 35% of colorectal cancer (CRC) risk, and almost
30% of the population in the UK have a family history of CRC. The quantification of an …

These consensus guidelines were jointly commissioned by the British Society of
Gastroenterology (BSG), the Association of Coloproctology of Great Britain and Ireland …

Background Treatment guidelines recommend a stepwise approach to primary biliary
cholangitis: all patients begin treatment with ursodeoxycholic acid (UDCA) monotherapy and …

These guidelines provide an evidence-based framework for the management of patients
with large non-pedunculated colorectal polyps (LNPCPs), in addition to identifying key …